Director, Headache Medicine and Headache Center
Director, Pediatric Neurology
Center for Neurologic Diseases
A board certified and fellowship trained neurologist, Dr. Mitra Assadi is director of Headache Medicine and the Headache Center at the Capital Institute for Neurosciences at Capital Health. Part of the Institute’s Center for Neurologic Diseases, Dr. Assadi also serves as director of Pediatric Neurology.
At the Headache Center, Dr. Assadi offers a multidisciplinary approach to patients and a variety of services for patients including nerve blocks, Botox injection, acupuncture, cervical manipulations as well as behavioral and relaxation therapy. The pediatric neurology program provides a comprehensive range of services including skin and muscle biopsy and genetic testing for children with developmental delay, autism and genetic disorders.
Board certified in neurology and clinical neurophysiology, Dr. Assadi was among one of the first neurologists in the United States to obtain a board certification in headache medicine in 2008. Her research in the epidemiology of migraine in adolescents was awarded the first place prize in the nation in 2010 by Young Epidemiological Scholars in Washington DC.
After completing her medical degree, Dr. Assadi held a research fellowship position at the National Institutes of Health (NIH). Subsequently, she completed her residency in neurology at Drexel University and a pediatric neurology fellowship at St. Christopher’s Hospital for Children. In 1998, Dr. Assadi was employed by Cooper Hospital, where she remained for 14 years. At Cooper Hospital, she served as the director of the EEG Lab and the headache program.
Dr. Assadi is actively involved in teaching and research. In 2008, she was promoted to Associate Professor of Neurology and Pediatrics at Robert Wood Johnson Medical School, a position which she will maintain while at Capital Health. She is also an Adjunct Professor of Neurology and Pediatrics at Rowan Medical School.
Dr. Assadi’s research has mostly focused on neuro-genetic disorders, in particular leukodystrophies. She has served as a clinical investigator at the Center for Cell and Gene Therapy at University of Medicine and Dentistry of New Jersey since 2004. In addition, she has been involved in the NIH sponsored gene therapy research for Canavan Disease, which was conducted at the Gene Therapy Center. She has special expertise in Canavan Disease and her published research on the use of lithium in Canavan patients has established the standard of care for these patients in the scientific community. She continues to collaborate with the Gene Therapy Center, where the next project will involve using stem cell therapy for Canavan Disease.
Dr. Assadi is well respected by her peers and was selected by them as a "TOP DOC" in SJ Magazine and South Jersey magazine both in 2010 and 2011.